Drugs / 13C6-Glipizide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05159427 | Mar 2022 → Mar 2026 | — | University of Michigan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C6-Glipizide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05159427 ↗ |
| Route | Oral | “Participants will take 1 mg of this study drug dissolved in 40 ml glucose solution by mouth.” NCT05159427 ↗ |